The effects of thermal injury on transcellular permeability and intestinal P-glycoprotein in rats

被引:6
|
作者
Neudeck, BL
Foster, DR
Li, LY
Gonzales, JP
Welage, LS
机构
[1] Univ Michigan, Coll Pharm, Ann Arbor, MI 48109 USA
[2] Univ Wisconsin, Sch Pharm, Madison, WI USA
[3] Purdue Univ, Dept Pharm Practice, Sch Pharm & Pharmacal Sci, Indianapolis, IN USA
[4] Pfizer Global Res & Dev, Dept Pharmacokinet Dynam & Metab, La Jolla Labs, San Diego, CA USA
[5] Cleveland Clin Fdn, Dept Pharm Serv, Cleveland, OH 44195 USA
[6] Univ Michigan Hlth Syst, Dept Pharm Serv, Ann Arbor, MI USA
关键词
P-glycoprotein; thermal injury; transcellular permeability;
D O I
10.1016/S0305-4179(03)00195-5
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
This study was designed to assess intestinal drug transport via transcellular absorption and intestinal P-glycoprotein content following thermal injury in rats using propranolol as a marker substrate. Male, Sprague Dawley rats (n = 30) underwent either a 30% total body surface area full thickness burn or sham treatment. Twenty-four hours later, animals were anesthetized, underwent laparotomy and the proximal jejunum was cannulated. The jejunal segment was perfused with buffer containing [H-3] propranolol. Following euthanasia, jejunal tissue was harvested for Western immunoblotting of P-glycoprotein and villin, and immunohistochemical analysis of P-glycoprotein. Dramatic structural changes in jejunal integrity were observed following thermal injury; however, no significant differences in the absorption characteristics of propranolol following thermal injury were observed. Mean effective permeability of propranolol was 5.67 +/- 1.79 and 5.85 +/- 1.67 cm/s x 10(-5) for burn and sham groups, respectively (P > 0.05). P-glycoprotein and villin content in the jejunum were significantly decreased in burn animals. The transcellular transport of propranolol is unaffected 24 It following thermal injury in rats, despite alterations in intestinal P-glycoprotein content. The decrease in P-glycoprotein and villin content in thermally injured animals may reflect loss of mature enterocytes at the villus tips. (C) 2003 Elsevier Ltd and ISBI. All rights reserved.
引用
收藏
页码:803 / 809
页数:7
相关论文
共 50 条
  • [21] Effects of β-cyclodextrin on the intestinal absorption of berberine hydrochloride, a P-glycoprotein substrate
    Zhang, Ye
    Cui, Yuan-Lu
    Gao, Li-Na
    Jiang, Heng-Li
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2013, 59 : 363 - 371
  • [22] The pharmacological role of P-glycoprotein in the intestinal epithelium
    Van Asperen, J
    Van Tellingen, O
    Beijnen, JH
    PHARMACOLOGICAL RESEARCH, 1998, 37 (06) : 429 - 435
  • [23] Intestinal P-glycoprotein inhibitors, benzoxanthone analogues
    Chae, Song Wha
    Lee, Jaeok
    Park, Jung Hyun
    Kwon, Youngjoo
    Na, Younghwa
    Lee, Hwa Jeong
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2018, 70 (02) : 234 - 241
  • [24] Deletion of the P-glycoprotein (mdr1a) gene unmasks regional variations in transcellular permeability in isolated mouse intestine in vitro
    Stephens, RH
    Warhurst, G
    JOURNAL OF PHYSIOLOGY-LONDON, 2002, 543 : 53P - 54P
  • [25] Effect of efavirenz on intestinal p-glycoprotein and hepatic p450 function in rats.
    Berruet, N
    Sentenac, S
    Auchere, D
    Gimenez, F
    Farinotti, R
    Fernandez, C
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2005, 8 (02): : 226 - 234
  • [26] Effect of P-Glycoprotein on the Rat Intestinal Permeability and Metabolism of the BDDCS Class 1 Drug Verapamil
    Estudante, Margarida
    Maya, Manuela
    Morais, Jose G.
    Soveral, Graca
    Benet, Leslie Z.
    MOLECULAR PHARMACEUTICS, 2013, 10 (11) : 4038 - 4045
  • [27] Prediction of in vivo intestinal absorption enhancement on P-glycoprotein inhibition, from rat in situ permeability
    Varma, MVS
    Panchagnula, R
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 94 (08) : 1694 - 1704
  • [28] Influence of Passive Permeability on Apparent P-glycoprotein Kinetics
    Kimberley A. Lentz
    Joseph W. Polli
    Stephen A. Wring
    Joan E. Humphreys
    James E. Polli
    Pharmaceutical Research, 2000, 17 : 1456 - 1460
  • [29] Involvement of P-glycoprotein transporters in the brain permeability of corticosteroids
    Arya, V
    Issar, M
    Shrestha, S
    Hochhaus, G
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (09): : 1059 - 1059
  • [30] Influence of passive permeability on apparent P-glycoprotein kinetics
    Lentz, KA
    Polli, JW
    Wring, SA
    Humphreys, JE
    Polli, JE
    PHARMACEUTICAL RESEARCH, 2000, 17 (12) : 1456 - 1460